Joshua Michael Moran is a Chicago, Illinois based male rheumatologist who is specialized in Rheumatology. Active license number of Joshua Michael Moran for Rheumatology is 036.169806 in Illinois. Joshua Michael Moran treat joint disease similar to orthopedists but do not perform surgeries. He diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Joshua Michael Moran speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Gender:
Male
Practice Address:
1801 W Taylor St # 3d, Chicago, Illinois, 60612-4795
Phone:
312-413-5569
Fax:
312-413-7835
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1578198354
NPI Enumeration Date:
11 Mar, 2020
NPI Last Update On:
26 Jun, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Joshua Michael Moran are as mentioned below.
License Number
Specialization
State
Status
036.169806
Rheumatologist
Illinois
Primary
036.169806
Internal Medicine
Illinois
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
818 S. Wolcott Ave. 6th Floor, Chicago, Illinois
Zip:
60612-3704
Phone Number:
312-355-6167
Fax Number:
312-413-9271
Patients can reach Joshua Michael Moran at 1801 W Taylor St # 3d, Chicago, Illinois or can call to book an appointment on 312-413-5569. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.